Literature DB >> 3165254

Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells.

K N Fedde1, C C Lane, M P Whyte.   

Abstract

Alkaline phosphatase (ALP) was examined in cultured human osteosarcoma cells (SAOS-2) with respect to isoenzyme form, kinetic properties toward two natural substrates, and topography and nature of attachment to the plasma membrane. ALP in SAOS-2 homogenates is the tissue-nonspecific (TNS) isoenzyme and a phosphoethanolamine (PEA) and pyridoxal 5'-phosphate (PLP) phosphatase, as demonstrated by heat and inhibition profiles and electrophoretic mobility. Kinetic studies indicate that TNSALP in SAOS-2 cells has both a low- and a high-affinity activity. The high-affinity activity (showing the greater catalytic efficiency) is active at physiologic pH toward physiologic concentrations (microM) of PEA and PLP. TNSALP was shown to be an ectoenzyme in SAOS-2 cells by our findings in intact cell suspensions, where (i) PEA and PLP degradation in the medium nearly equaled that of whole cell homogenates, (ii) greater than 85% of ALP activity was inactivated by acid treatment, and (iii) ALP activity was quantitatively released by phosphatidylinositol-specific phospholipase C. Our findings indicate that, in SAOS-2 cells, TNS (bone) ALP functions as an ectoenzyme to degrade physiologic concentrations of extracellular natural substrates at physiologic pH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165254     DOI: 10.1016/0003-9861(88)90305-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  21 in total

1.  Increased plasma pyridoxal-5'-phosphate levels before and after pyridoxine loading in carriers of perinatal/infantile hypophosphatasia.

Authors:  B N Chodirker; S P Coburn; L E Seargeant; M P Whyte; C R Greenberg
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms.

Authors:  Cecilia Halling Linder; Sonoko Narisawa; José Luis Millán; Per Magnusson
Journal:  Bone       Date:  2009-07-22       Impact factor: 4.398

Review 3.  Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors:  Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

4.  Structural and Functional Characterization of the Histidine Phosphatase Domains of Human Sts-1 and Sts-2.

Authors:  Weijie Zhou; Yue Yin; Alexandra S Weinheimer; Neena Kaur; Nick Carpino; Jarrod B French
Journal:  Biochemistry       Date:  2017-08-21       Impact factor: 3.162

5.  Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study.

Authors:  K N Fedde; M P Whyte
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

6.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

7.  Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia.

Authors:  P S Henthorn; M Raducha; K N Fedde; M A Lafferty; M P Whyte
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

8.  Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture.

Authors:  P Collin; J R Nefussi; A Wetterwald; V Nicolas; M L Boy-Lefevre; H Fleisch; N Forest
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

9.  Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities.

Authors:  Scott J Roberts; Alan J Stewart; Peter J Sadler; Colin Farquharson
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

10.  Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown.

Authors:  A U Ziganshin; L E Ziganshina; B E King; G Burnstock
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.